PHARMA MAR, S.A. «...678910...» Page 6 out of 22 27/07/2023 17:47 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company sends press release regarding first half 2023 results and announces a conference call with analysts and investors. Register number: 23908 27/07/2023 17:42 PHARMA MAR, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2023 Register number: 23906 19/07/2023 15:42 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner Immedica Pharma AB has received the full approval for commercialization for Zepzelca® (lurbinectedina) in Oman. Register number: 23673 11/07/2023 13:15 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner, Lotus Pharmaceutical CO., Ltd., has received accelerated marketing approval for Zepzelca® (lurbinectedina) in Taiwan. Register number: 23542 05/07/2023 17:42 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/04/2023 and 30/06/2023 Register number: 23453 06/06/2023 14:26 PHARMA MAR, S.A. On business and financial situation The Company announces together with its partner Luye Pharma Group Ltd. the acceptance of New Drug Application for lurbinectedin in China. Register number: 22872 31/05/2023 13:51 PHARMA MAR, S.A. Other relevant information The Company informs about the dividend payment Register number: 22801 31/05/2023 13:30 PHARMA MAR, S.A. On corporate governance The Company reports changes in the composition of its Board of Directors and its Committees. Register number: 22800 31/05/2023 13:19 PHARMA MAR, S.A. Announcement of general shareholders’ meeting It is reported that all proposed resolutions submitted by the Board to the General Shareholders’ Meeting have been approved. Register number: 22799 31/05/2023 11:15 PHARMA MAR, S.A. Announcement of general shareholders’ meeting Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman and by the Chief Financial Officer of the Company. Register number: 22794 Page 6 out of 22 «...678910...»